CureGenetics

CureGenetics was founded in May 2023, with its headquarters located in Bengbu, Anhui. It is a biotechnology company that develops gene editing technologies, molecular diagnostic products, and novel anti-tumor drugs based on the CRISPR/Cas system. The company’s main products include the CRISPR/Cas12Max Gene Detection Kit: used for precise clinical diagnosis of respiratory system tumors and infectious diseases; and a novel controllable CRISPR gene editing system: supporting molecular diagnostic reagents, applied in the field of gene therapy research and development.